There are benign and malignant uterine tumors. Common benign tumors are uterine fibroids and uterine adenomyoma; malignant tumors broadly speaking include endometrial cancer, cervical cancer and uterine sarcoma, but clinically they usually refer to tumors of uterine body in a narrow sense, i.e. endometrial cancer and uterine sarcoma. Uterine fibroids: They occur in the reproductive age, commonly in women from 30-50. They can be solitary or multiple, and are divided into 3 categories depending on their relationship with the uterine wall: interstitial fibroids, which account for 60-70% of the cases, are located between the walls of the uterus and wrapped by the muscular layer; subplasma fibroids, which account for 20% of the cases, protrude from the surface of the uterus and may be attached to the uterus; and submucosal fibroids, which protrude from the uterine cavity and may be attached to the vagina. Uterine fibroids often have different symptoms depending on their location. Interstitial fibroids or subplasmic fibroids are often clinically asymptomatic and are only found incidentally during physical examination. If the fibroids are small and asymptomatic, they do not require treatment; they are followed up regularly. Submucosal leiomyosarcoma often leads to excessive or irregular menstrual bleeding, and surgery is recommended for those with obvious symptoms, such as anemia secondary to excessive menstruation. In addition, myomas that are too large, myoma twisting inducing acute abdomen, myoma degeneration inducing severe abdominal pain, etc. should be treated surgically. Endometrial cancer: Epithelial malignant tumors occurring in the endometrium, with adenocarcinoma being the most common. Most patients show symptoms of vaginal bleeding or vaginal discharge, especially those with postmenopausal bleeding should be alerted. The diagnosis of endometrial cancer requires hysteroscopy or hysteroscopic surgery. Once diagnosed, surgery should be performed immediately. Total hysterectomy and bilateral adnexal resection, pelvic lymph node dissection and para-abdominal aortic lymph node dissection should be performed if necessary. Depending on the pathological stage, surgery should be followed by radiotherapy or hormone therapy. Radiotherapy, chemotherapy and progesterone therapy can also be used for inoperable patients. Uterine sarcoma: It is rare but highly malignant. Surgery is the main treatment principle, followed by chemotherapy or radiotherapy, and most of them have a very poor prognosis with a 5-year survival rate of 20-30%.